Accuray to cut 5% of workforce

Fresh off the news that Stryker ($SYK) was cutting jobs, Accuray ($ARAY) has said it also is cutting 5% of its workforce, or 51 jobs, to reduce costs following its earlier acquisition of TomoTherapy. The company has already cut 29 positions as of Nov. 15 and will eliminate the remaining 22 jobs in phases over fiscal 2012, Reuters notes.

The company will record a charge of about $1.7 million related to the Nov. 15 job cut in the second quarter.

Back in March, Accuray agreed to buy TomoTherapy, a creator of radiation therapy solutions for cancer care, for $4.80 per share in cash and stock, or approximately $277 million.

- get more from Reuters

Suggested Articles

Longitude Capital invests in what its founders call “transformative healthcare companies," working in areas they hope will increase quality of life.

The FDA launched a center of excellence to oversee digital health products such as smartphone apps, wearable devices and software-based treatments.

The immunoassay will measure neurofilament light chain protein levels, found in the blood and cerebrospinal fluid, and linked to nerve damage.